Nilotinib (Tasigna)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Nilotinib (Tasigna), covering 2011-07-13 to 2024-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia [Phase 2]